PHARMACEUTICAL COMPOSITION
Application
US20260097081A1
Kind: A1
Apr 09, 2026
Assignee
FUKUOKA UNIVERSITY
Inventors
Shohta KODAMA, Masuhiro Nishimura, Shinichi Matsumoto, Osamu Sawamoto
Abstract
An object of the present invention is to provide a pharmaceutical composition containing mesenchymal stem cells that exhibit excellent therapeutic effects on various diseases, injured parts, wounds and decubitus. The present invention relates to a pharmaceutical composition for treating a non-porcine animal, the pharmaceutical composition includes a neonatal pig-derived mesenchymal stem cell which produces at least one humoral factor selected from TGF-β1, TGF-β2, VEGF-A and VEGF-C.
CPC Classifications
A61K 35/28
A61P 9/10
A61P 17/02
Filing Date
2025-10-10
Application No.
19355935